Ascentage Pharma Group International Net Tangible Assets

Ascentage Pharma Group International (ASPHF) currently reports a net tangible assets of $570M as of June 2026. That compares with $680M in the prior-year period — down 16.3% year over year. Use the charts on this page to explore Ascentage Pharma Group International's net tangible assets history and peer comparisons.

Ascentage Pharma Group International's net tangible assets decreased from $680M to $570M — a 16.3% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Ascentage Pharma Group International reported $570M in net tangible assets as of June 2026. That compares with $680M in the prior-year period — down 16.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $570M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Ascentage Pharma Group International, and consider following ASPHF for alerts when major investors trade the stock.

Ascentage Pharma Group International is classified in the Healthcare sector. On net tangible assets, it currently shows $570M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ASPHF with unrelated industries.